Cargando…
Multimarker Panels for Detection of Early Stage Hepatocellular Carcinoma: A Prospective, Multicenter, Case‐Control Study
Hepatocellular carcinoma (HCC), the sixth most common cancer worldwide, has an incidence rate equal to mortality. Over 80% of HCC cases occur within a high‐risk population, mainly patients with both cirrhosis and chronic hepatitis B or C. With a 5‐year survival rate ranging from <16% for advanced...
Autores principales: | Piratvisuth, Teerha, Tanwandee, Tawesak, Thongsawat, Satawat, Sukeepaisarnjaroen, Wattana, Esteban, Juan Ignacio, Bes, Marta, Köhler, Bruno, He, Ying, Swiatek‐de Lange, Magdalena, Morgenstern, David, Chan, Henry Lik‐Yuen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8948551/ https://www.ncbi.nlm.nih.gov/pubmed/34796691 http://dx.doi.org/10.1002/hep4.1847 |
Ejemplares similares
-
Discovery of a haptoglobin glycopeptides biomarker panel for early diagnosis of hepatocellular carcinoma
por: Kohansal-Nodehi, Mahdokht, et al.
Publicado: (2023) -
Comprehensive evaluation of microRNA as a biomarker for the diagnosis of hepatocellular carcinoma
por: Malik, Juliane, et al.
Publicado: (2022) -
Vitamin D-Binding protein Gene Polymorphism Predicts Pegylated Interferon-Related HBsAg Seroclearance in HBeAg-Negative Thai Chronic Hepatitis B Patients: A Multicentre Study
por: Thanapirom, Kessarin, et al.
Publicado: (2019) -
Genetic variation in the vitamin D pathway CYP2R1 gene predicts sustained HBeAg seroconversion in chronic hepatitis B patients treated with pegylated interferon: A multicenter study
por: Thanapirom, Kessarin, et al.
Publicado: (2017) -
Acute‐on‐chronic liver failure: Epidemiology, prognosis, and outcome of a multicenter study in Thai population
por: Chirapongsathorn, Sakkarin, et al.
Publicado: (2022)